<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02307253</url>
  </required_header>
  <id_info>
    <org_study_id>7427/13</org_study_id>
    <nct_id>NCT02307253</nct_id>
  </id_info>
  <brief_title>EUS GUIDED Transduodenal Biopsy Using the 19G Flex</brief_title>
  <acronym>NIFLEX</acronym>
  <official_title>EUS-guided Fine Needle Tissue Acquisition Using a Newly Developed Nitinol Ultra Flex 19 Gauge Needle for Transduodenal Lesions: a Multicenter Prospective Feasibility Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Catholic University of the Sacred Heart</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Catholic University of the Sacred Heart</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the feasibility, safety and accuracy of a 19 gauge (19G) needle in
      nitinol in the performance of endoscopic ultrasound (EUS) guided transduodenal biopsy for the
      acquisition of samples for histologic analysis. Patients with lesions that can be approached
      only from the duodenum will be prospectively enrolled.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A 19 gauge needle in nitinol (Flex needle) has been recently become available for EUS guided
      procedure.

      The use of nitinol should guarantee a better needle flexibility with a theoretical advantage
      on the use of this needle for lesions that need to be sampled through the duodenum. Moreover,
      samples for histologic examination seems to be easy to interpret than cytologic ones allowing
      evaluate of the overall architecture of the tissue, better performance of immunohistochemical
      staining, and may be of additional value to perform tissue profiling that in the future will
      be very important to guide individualized therapies

      The existing data on the performance of the Flex needle for EUS-guided transduodenal biopsy
      are coming form a single study performed in one single center. Thus, the reproducibility of
      these results is unknown and multicenter prospective studies are warranted to answer this
      important question.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">August 2015</completion_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients in which it was possible to place the needle within the target lesion by a transduodenal route divided by the total number of enrolled patients.</measure>
    <time_frame>Intraoperative</time_frame>
    <description>capability of performing EUS-FNTA through the duodenum by placing the target lesion in the proper position with insertion of the needle into the lesion</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of complications divided per total number of enrolled patients</measure>
    <time_frame>intraoperative and within 3 days after the procedure</time_frame>
    <description>rate of complications, divided in procedural complication (perforation, bleeding) occurring during the procedure and late complications (delayed bleeding, infection) occurring during the post-procedural observational period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of histological samples judged adequate divided by the total number of patients</measure>
    <time_frame>5 days</time_frame>
    <description>percentage of patients in whom a histologically interpretable specimen will be retrieved</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of correct diagnosis divided by the total number of patients</measure>
    <time_frame>6 months</time_frame>
    <description>rate of correct diagnosis obtained through analysis of the tissue samples acquired with EUS fine needle biopsy</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Abdominal Neoplasms</condition>
  <arm_group>
    <arm_group_label>patients with solid lesions</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Expect™19Flex needle (Boston Scientific Corp.,Natick,MA,USA)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Expect™19Flex needle (Boston Scientific Corp.,Natick,MA,USA)</intervention_name>
    <description>EUS-guided fine needle biopsy performed through the duodenum with the Expect™ 19 Flex needle</description>
    <arm_group_label>patients with solid lesions</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        A. Age greater than 18 and less than 90. B. Presence of a solid lesion of the
        gastrointestinal tract adjacent to the duodenum with no previous tissue diagnosis.

        C. Absence of an uncorrectable coagulopathy as defined by abnormal prothrombin time (PT) or
        partial thromboplastin time (PTT) that does not normalize after administration of fresh
        frozen plasma.

        D. Informed consent is obtained.

        Exclusion Criteria:

        A. Presence of an uncorrectable coagulopathy as defined by abnormal prothrombin time (PT)
        or partial thromboplastin time (PTT) that does not normalize after administration of fresh
        frozen plasma.

        B. Altered anatomy of the upper gastrointestinal tract due to surgery of the esophagus,
        stomach and duodenum.

        C. They are unable to understand and/or read the consent form.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guido Costamagna, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Catholic University of the Sacred Heart</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alberto Larghi, MD, PhD</last_name>
    <phone>+390630156580</phone>
    <email>albertolarghi@yahoo.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>carolina Gualtieri, manager</last_name>
    <phone>+390630156580</phone>
    <email>c.gualtieri@eetc.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Indiana Univerisity Health Medical Center</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John DeWitt, MD</last_name>
      <phone>317-944-1113</phone>
      <email>jodewitt@iu.edu</email>
    </contact>
    <contact_backup>
      <last_name>Kathy McGreevy, RN</last_name>
      <phone>3179445392</phone>
      <email>kmcgreev@iu.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Clinique du Trocadero</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurant Palazzo</last_name>
      <phone>0033147421551</phone>
      <email>laurent.palazzo@wanadoo.fr</email>
    </contact>
    <contact_backup>
      <last_name>Laurence BONNAUD</last_name>
      <phone>0033147421551</phone>
      <email>laurencechristine92@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>AUSL Bologna Bellaria-Maggiore Hospital</name>
      <address>
        <city>Bologna</city>
        <zip>40139</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carlo Fabbri, MD</last_name>
      <phone>+393389353104</phone>
      <email>carlo.fabbri@ausl.bo.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>ISMETT UPMC Italy</name>
      <address>
        <city>Palermo</city>
        <zip>90100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ilaria Tarantino, MD</last_name>
      <phone>+393357357728</phone>
      <email>itarantino@ismett.edu</email>
    </contact>
    <contact_backup>
      <last_name>Maria Grazia Puleo</last_name>
      <phone>+390912192111</phone>
      <email>mgpuleo@ismett.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Digestive Endoscopy Unit, Universita' Cattolica del Sacro Cuore</name>
      <address>
        <city>Rome</city>
        <zip>00168</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Teikyo University Mizonokuchi Hospital, Departement of Gastroenterology</name>
      <address>
        <city>Kawasaki</city>
        <state>Kanagawa</state>
        <zip>213-8507</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ichiro Yasuda, MD, PhD</last_name>
      <phone>+81 44 844 3333</phone>
      <email>yasudaich@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Shinpei Doi, MD, PhD</last_name>
      <phone>+81 44 844 3333</phone>
      <email>sinpesan@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
    <country>Italy</country>
    <country>Japan</country>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Varadarajulu S, Bang JY, Hebert-Magee S. Assessment of the technical performance of the flexible 19-gauge EUS-FNA needle. Gastrointest Endosc. 2012 Aug;76(2):336-43. doi: 10.1016/j.gie.2012.04.455.</citation>
    <PMID>22817786</PMID>
  </results_reference>
  <verification_date>November 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 19, 2014</study_first_submitted>
  <study_first_submitted_qc>December 1, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 4, 2014</study_first_posted>
  <last_update_submitted>December 1, 2014</last_update_submitted>
  <last_update_submitted_qc>December 1, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 4, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Catholic University of the Sacred Heart</investigator_affiliation>
    <investigator_full_name>Guido Costamagna</investigator_full_name>
    <investigator_title>Professor of Surgery</investigator_title>
  </responsible_party>
  <keyword>EUS-guided biopsy, EUS-FNB</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Abdominal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

